PLK1 and osteosarcoma: Liang group kinome‐wide clustered regularly interspaced short palindromic repeat (CRISPR)‐associated protein (Cas) 9 knockout screenings have identified PLK1 as a critical kinase for the survival and proliferation of human osteosarcoma cells, offering new insights and potential therapeutic avenues for this aggressive cancer.12